Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine
Tóm tắt
Mesenchymal stem cells (MSC) hold great potential for regenerative medicine because of their ability for self-renewal and differentiation into tissue-specific cells such as osteoblasts, chondrocytes, and adipocytes. MSCs orchestrate tissue development, maintenance and repair, and are useful for musculoskeletal regenerative therapies to treat age-related orthopedic degenerative diseases and other clinical conditions. Importantly, MSCs produce secretory factors that play critical roles in tissue repair that support both engraftment and trophic functions (autocrine and paracrine). The development of uniform protocols for both preparation and characterization of MSCs, including standardized functional assays for evaluation of their biological potential, are critical factors contributing to their clinical utility. Quality control and release criteria for MSCs should include cell surface markers, differentiation potential, and other essential cell parameters. For example, cell surface marker profiles (surfactome), bone-forming capacities in ectopic and orthotopic models, as well as cell size and granularity, telomere length, senescence status, trophic factor secretion (secretome), and immunomodulation, should be thoroughly assessed to predict MSC utility for regenerative medicine. We propose that these and other functionalities of MSCs should be characterized prior to use in clinical applications as part of comprehensive and uniform guidelines and release criteria for their clinical-grade production to achieve predictably favorable treatment outcomes for stem cell therapy.
Từ khóa
Tài liệu tham khảo
Corselli, 2013, Perivascular support of human hematopoietic stem/progenitor cells, Blood, 121, 2891, 10.1182/blood-2012-08-451864
Crisan, 2008, A perivascular origin for mesenchymal stem cells in multiple human organs, Cell Stem Cell, 3, 301, 10.1016/j.stem.2008.07.003
Blocki, 2013, Not all MSCs can act as pericytes: Functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis, Stem Cells Dev, 22, 2347, 10.1089/scd.2012.0415
Sacchetti, 2007, Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment, Cell, 131, 324, 10.1016/j.cell.2007.08.025
Samsonraj, 2015, Establishing criteria for human mesenchymal stem cell potency, Stem Cells, 33, 1878, 10.1002/stem.1982
Friedenstein, 1970, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell Tissue Kinet, 3, 393
Castro-Malaspina, 1980, Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny, Blood, 56, 289, 10.1182/blood.V56.2.289.289
Song, 2004, Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow, FASEB J, 18, 980, 10.1096/fj.03-1100fje
Crain, 2005, Transplanted human bone marrow cells generate new brain cells, J Neurol Sci, 233, 121, 10.1016/j.jns.2005.03.017
Krabbe, 2005, Neural transdifferentiation of mesenchymal stem cells–a critical review, APMIS, 113, 831, 10.1111/j.1600-0463.2005.apm_3061.x
Ries, 2012, Stem Cells and Cancer Stem Cells, Volume 8: Therapeutic Applications in Disease and Injury, 71, 10.1007/978-94-007-4798-2_7
Kopen, 1999, Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proc Natl Acad Sci USA, 96, 10711, 10.1073/pnas.96.19.10711
Aguilar, 2016, Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampus, Biochim Biophys Acta, 1859, 1043, 10.1016/j.bbagrm.2016.05.009
Okolicsanyi, 2015, Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion, PLoS One, 10, e0137255, 10.1371/journal.pone.0137255
Aust, 2004, Yield of human adipose-derived adult stem cells from liposuction aspirates, Cytotherapy, 6, 7, 10.1080/14653240310004539
Smiler, 2008, Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration, Implant Dent, 17, 236, 10.1097/ID.0b013e3181835b13
He, 2007, Concise review: Multipotent mesenchymal stromal cells in blood, Stem Cells, 25, 69, 10.1634/stemcells.2006-0335
Griffiths, 2005, Stem cells of the alveolar epithelium, Lancet, 366, 249, 10.1016/S0140-6736(05)66916-4
Tuli, 2003, Current state of cartilage tissue engineering, Arthritis Res Ther, 5, 235, 10.1186/ar991
Fan, 2009, Synovium-derived mesenchymal stem cells: A new cell source for musculoskeletal regeneration, Tissue Eng Part B Rev, 15, 75, 10.1089/ten.teb.2008.0586
Gay, 2007, Isolation and characterization of multipotent human periodontal ligament stem cells, Orthod Craniofac Res, 10, 149, 10.1111/j.1601-6343.2007.00399.x
Jackson, 2010, Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells, Expert Opin Biol Ther, 10, 505, 10.1517/14712591003610606
In't Anker, 2004, Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta, Stem Cells, 22, 1338, 10.1634/stemcells.2004-0058
Miao, 2006, Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells, Cell Biol Int, 30, 681, 10.1016/j.cellbi.2006.03.009
Corrao, 2013, Umbilical cord revisited: From Wharton's jelly myofibroblasts to mesenchymal stem cells, Histol Histopathol, 28, 1235
Erices, 2000, Mesenchymal progenitor cells in human umbilical cord blood, Br J Haematol, 109, 235, 10.1046/j.1365-2141.2000.01986.x
Mareschi, 2001, Isolation of human mesenchymal stem cells: Bone marrow versus umbilical cord blood, Haematologica, 86, 1099
Seo, 2004, Investigation of multipotent postnatal stem cells from human periodontal ligament, Lancet, 364, 149, 10.1016/S0140-6736(04)16627-0
Shi, 2003, Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp, J Bone Miner Res, 18, 696, 10.1359/jbmr.2003.18.4.696
Corselli, 2010, Perivascular ancestors of adult multipotent stem cells, Arterioscler Thromb Vasc Biol, 30, 1104, 10.1161/ATVBAHA.109.191643
Elahi, 2016, Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns, Stem Cells Int, 2016, 5646384, 10.1155/2016/5646384
Kwon, 2016, Tissue-specific differentiation potency of mesenchymal stromal cells from perinatal tissues, Sci Rep, 6, 23544, 10.1038/srep23544
Davies, 2017, Concise review: Wharton's Jelly: The rich, but enigmatic, source of mesenchymal stromal cells, Stem Cells Translational Medicine, 6, 1620, 10.1002/sctm.16-0492
Chen, 2015, Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins, Asian Pac J Trop Med, 8, 739, 10.1016/j.apjtm.2015.07.022
Billing, 2016, Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers, Sci Rep, 6, 21507, 10.1038/srep21507
Sakaguchi, 2005, Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source, Arthritis Rheum, 52, 2521, 10.1002/art.21212
Rider, 2007, Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells, J Mol Histol, 38, 449, 10.1007/s10735-007-9128-z
Hass, 2011, Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC, Cell Commun Signal CCS, 9, 12, 10.1186/1478-811X-9-12
Maleki, 2014, Comparison of mesenchymal stem cell markers in multiple human adult stem cells, Int J Stem Cells, 7, 118, 10.15283/ijsc.2014.7.2.118
Trounson, 2015, Stem cell therapies in clinical trials: Progress and challenges, Cell Stem Cell, 17, 11, 10.1016/j.stem.2015.06.007
Monsarrat, 2016, An innovative, comprehensive mapping and multiscale analysis of registered trials for stem cell-based regenerative medicine, Stem Cells Translational Medicine, 5, 826, 10.5966/sctm.2015-0329
Atoui, 2012, Concise review: Immunomodulatory properties of mesenchymal stem cells in cellular transplantation: Update, controversies, and unknowns, Stem Cells Translational Medicine, 1, 200, 10.5966/sctm.2011-0012
Steinert, 2012, Concise review: The clinical application of mesenchymal stem cells for musculoskeletal regeneration: Current status and perspectives, Stem Cells Translational Medicine, 1, 237, 10.5966/sctm.2011-0036
Hare, 2012, Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial, JAMA, 308, 2369, 10.1001/jama.2012.25321
Kinkaid, 2010, What's new in cardiac cell therapy? Allogeneic bone marrow stromal cells as “universal donor cells, J Card Surg, 25, 359, 10.1111/j.1540-8191.2009.00984.x
Zhang, 2015, The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy, Stem Cell Res Ther, 6, 234, 10.1186/s13287-015-0240-9
Griffin, 2013, Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?, Stem Cells, 31, 2033, 10.1002/stem.1452
Alagesan, 2014, Autologous and allogeneic mesenchymal stem cells in organ transplantation: What do we know about their safety and efficacy?, Curr Opin Organ Transplant, 19, 65, 10.1097/MOT.0000000000000043
Grisendi, 2010, GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion, Cytotherapy, 12, 466, 10.3109/14653241003649510
Gronthos, 2003, Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow, J Cell Sci, 116, 1827, 10.1242/jcs.00369
Miltenyi, 1990, High gradient magnetic cell separation with MACS, Cytometry, 11, 231, 10.1002/cyto.990110203
Wagner, 2009, Optimizing mesenchymal stem cell-based therapeutics, Curr Opin Biotechnol, 20, 531, 10.1016/j.copbio.2009.08.009
Wagner, 2008, The stromal activity of mesenchymal stromal cells, Transfus Med Hemother, 35, 185, 10.1159/000128956
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
Friedenstein, 1974, Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp Hematol, 2, 83
Caplan, 2009, Why are MSCs therapeutic? New data: New insight, J Pathol, 217, 318, 10.1002/path.2469
Haynesworth, 1994, 79
Gronthos, 1994, The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors, Blood, 84, 4164, 10.1182/blood.V84.12.4164.bloodjournal84124164
Gronthos, 1995, The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro, Blood, 85, 929, 10.1182/blood.V85.4.929.bloodjournal854929
Gronthos, 1999, Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells, J Bone Miner Res, 14, 47, 10.1359/jbmr.1999.14.1.47
Simmons, 1991, Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1, Blood, 78, 55, 10.1182/blood.V78.1.55.55
Gang, 2007, SSEA-4 identifies mesenchymal stem cells from bone marrow, Blood, 109, 1743, 10.1182/blood-2005-11-010504
Jones, 2008, Human bone marrow mesenchymal stem cells in vivo, Rheumatology (Oxford), 47, 126, 10.1093/rheumatology/kem206
Buhring, 2007, Novel markers for the prospective isolation of human MSC, Ann N Y Acad Sci, 1106, 262, 10.1196/annals.1392.000
Quirici, 2002, Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies, Exp Hematol, 30, 783, 10.1016/S0301-472X(02)00812-3
Buhring, 2009, Phenotypic characterization of distinct human bone marrow-derived MSC subsets, Ann N Y Acad Sci, 1176, 124, 10.1111/j.1749-6632.2009.04564.x
Sobiesiak, 2010, The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase, Stem Cells Dev, 19, 669, 10.1089/scd.2009.0290
Halfon, 2011, Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging, Stem Cells Dev, 20, 53, 10.1089/scd.2010.0040
Jurisic, 2010, Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium, Exp Cell Res, 316, 2982, 10.1016/j.yexcr.2010.06.013
Kisselbach, 2009, CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures, Cytotechnology, 59, 31, 10.1007/s10616-009-9190-3
Ishii, 2005, Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts, Biochem Biophys Res Commun, 332, 297, 10.1016/j.bbrc.2005.04.118
Fitter, 2017, The mesenchymal precursor cell marker antibody STRO-1 binds to cell surface heat shock cognate 70, Stem Cells, 35, 940, 10.1002/stem.2560
Bianco, 2013, The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine, Nat Med, 19, 35, 10.1038/nm.3028
Arthur, 2009, The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair, J Cell Physiol, 218, 237, 10.1002/jcp.21592
Bourin, 2013, Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT), Cytotherapy, 15, 641, 10.1016/j.jcyt.2013.02.006
Andersen, 2011, Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells, Mol Cells, 32, 133, 10.1007/s10059-011-2277-7
Tormin, 2011, CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization, Blood, 117, 5067, 10.1182/blood-2010-08-304287
Boxall, 2012, Markers for characterization of bone marrow multipotential stromal cells, Stem Cells Int, 2012, 12, 10.1155/2012/975871
Deschaseaux, 2003, Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45(med, low) phenotype, Br J Haematol, 122, 506, 10.1046/j.1365-2141.2003.04469.x
Tormin, 2009, CD146 expression in primary bone marrow MSC progenitor/stem cells is dependent on their in vivo location, Blood, 114, 107, 10.1182/blood.V114.22.251.251
Jones, 2006, Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow, Cytometry B Clin Cytom, 70B, 391, 10.1002/cyto.b.20118
Jones, 2002, Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells, Arthritis Rheum, 46, 3349, 10.1002/art.10696
Battula, 2009, Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1, Haematologica, 94, 173, 10.3324/haematol.13740
Nombela-Arrieta, 2011, The elusive nature and function of mesenchymal stem cells, Nat Rev Mol Cell Biol, 12, 126, 10.1038/nrm3049
Mendez-Ferrer, 2010, Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature, 466, 829, 10.1038/nature09262
Morikawa, 2009, Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow, J Exp Med, 206, 2483, 10.1084/jem.20091046
Pinho, 2013, PDGFRα and CD51 mark human Nestin(+) sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion, J Exp Med, 210, 1351, 10.1084/jem.20122252
Zhou, 2014, Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow, Cell Stem Cell, 15, 154, 10.1016/j.stem.2014.06.008
Jones, 2015, Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species?, Stem Cell Res Ther, 6, 143, 10.1186/s13287-015-0144-8
Camilleri, 2016, Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production, Stem Cell Res Ther, 7, 107, 10.1186/s13287-016-0370-8
Ong, 2014, Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots, Stem Cell Reports, 2, 171, 10.1016/j.stemcr.2014.01.002
Reger, 2008, Differentiation and characterization of human MSCs, Methods Mol Biol, 449, 93
Sarugaser, 2009, Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy, PLoS One, 4, e6498, 10.1371/journal.pone.0006498
Bhakta, 2012, Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2, Biomaterials, 33, 6113, 10.1016/j.biomaterials.2012.05.030
Bramono, 2012, Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2), Bone, 50, 954, 10.1016/j.bone.2011.12.013
Dombrowski, 2013, FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21(Waf1) and p27(Kip1), Stem Cells, 31, 2724, 10.1002/stem.1514
Helledie, 2012, Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow, Stem Cells Dev, 21, 1897, 10.1089/scd.2011.0367
Ling, 2010, Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway, J Biol Chem, 285, 26233, 10.1074/jbc.M110.122069
Teplyuk, 2009, The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts, J Cell Biochem, 107, 144, 10.1002/jcb.22108
Scott, 2011, Current methods of adipogenic differentiation of mesenchymal stem cells, Stem Cells Dev, 20, 1793, 10.1089/scd.2011.0040
Johnstone, 1998, In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells, Exp Cell Res, 238, 265, 10.1006/excr.1997.3858
Mackay, 1998, Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow, Tissue Eng, 4, 415, 10.1089/ten.1998.4.415
Barry, 2001, Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components, Exp Cell Res, 268, 189, 10.1006/excr.2001.5278
Hoch, 2014, Concise review: Optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications, Stem Cells Translational Medicine, 3, 643, 10.5966/sctm.2013-0196
Riis, 2016, Comparative analysis of media and supplements on initiation and expansion of adipose-derived stem cells, Stem Cells Translational Medicine, 5, 314, 10.5966/sctm.2015-0148
Pountos, 2014, Mesenchymal stem cell physiology can be affected by antibiotics: An in vitro study, Cell Mol Biol (Noisy-le-grand), 60, 1
Petersen, 1999, Bone marrow as a potential source of hepatic oval cells, Science, 284, 1168, 10.1126/science.284.5417.1168
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Quinn, 2008, In vivo differentiation potential of mesenchymal stem cells: Prenatal and postnatal model systems, Transfus Med Hemother, 35, 239, 10.1159/000129129
Li, 2013, In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury, PLoS One, 8, e62363, 10.1371/journal.pone.0062363
Munoz-Elias, 2004, Adult bone marrow stromal cells in the embryonic brain: Engraftment, migration, differentiation, and long-term survival, J Neurosci, 24, 4585, 10.1523/JNEUROSCI.5060-03.2004
Bae, 2007, Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration, Stem Cells, 25, 1307, 10.1634/stemcells.2006-0561
Liu, 2015, The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases, J Cell Mol Med, 19, 511, 10.1111/jcmm.12482
Meier, 2013, Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?, Stem Cell Res, 11, 1348, 10.1016/j.scr.2013.08.011
Terada, 2002, Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion, Nature, 416, 542, 10.1038/nature730
Sottile, 2016, Mesenchymal stem cells generate distinct functional hybrids in vitro via cell fusion or entosis, Sci Rep, 6, 36863, 10.1038/srep36863
Nygren, 2004, Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation, Nat Med, 10, 494, 10.1038/nm1040
Muraglia, 2000, Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model, J Cell Sci, 113, 1161, 10.1242/jcs.113.7.1161
Pevsner-Fischer, 2011, The origins of mesenchymal stromal cell heterogeneity, Stem Cell Rev, 7, 560, 10.1007/s12015-011-9229-7
Russell, 2010, In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment, Stem Cells, 28, 788, 10.1002/stem.312
Kordelas, 2014, MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease, Leukemia, 28, 970, 10.1038/leu.2014.41
Lai, 2010, Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, Stem Cell Res, 4, 214, 10.1016/j.scr.2009.12.003
Amable, 2014, Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly, Stem Cell Res Ther, 5, 53-53, 10.1186/scrt442
Eirin, 2014, MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells, Gene, 551, 55, 10.1016/j.gene.2014.08.041
Eirin, 2016, Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells, Sci Rep, 6, 36120, 10.1038/srep36120
Hong, 2012, Perspectives on mesenchymal stem cells: Tissue repair, immune modulation, and tumor homing, Arch Pharm Res, 35, 201, 10.1007/s12272-012-0201-0
Marfy-Smith, 2017, Are mesenchymal stem cells so bloody great after all?, Stem Cells Translational Medicine, 6, 3, 10.5966/sctm.2016-0026
Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X
Ortiz, 2007, Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury, Proc Natl Acad Sci USA, 104, 11002, 10.1073/pnas.0704421104
Shabbir, 2009, Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: A noninvasive therapeutic regimen, Am J Physiol Heart Circ Physiol, 296, H1888, 10.1152/ajpheart.00186.2009
Dexter, 1989, Regulation of hemopoietic cell growth and development: Experimental and clinical studies, Leukemia, 3, 469
Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559
Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838
Centeno, 2008, Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells, Med Hypotheses, 71, 900, 10.1016/j.mehy.2008.06.042
Andrews, 2008, Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat, Exp Neurol, 211, 588, 10.1016/j.expneurol.2008.02.027
Shabbir, 2010, Activation of host tissue trophic factors through JAK-STAT3 signaling: A mechanism of mesenchymal stem cell-mediated cardiac repair, Am J Physiol Heart Circ Physiol, 299, H1428, 10.1152/ajpheart.00488.2010
Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, Nat Med, 5, 309, 10.1038/6529
Luong-Van, 2007, The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cells, J Mol Histol, 38, 459, 10.1007/s10735-007-9129-y
Singer, 2011, Mesenchymal stem cells: Mechanisms of inflammation, Annu Rev Pathol, 6, 457, 10.1146/annurev-pathol-011110-130230
Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper, J Extracell Vesicles, 4, 30087, 10.3402/jev.v4.30087
Cruz, 2015, Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice, Stem Cells Translational Medicine, 4, 1302, 10.5966/sctm.2014-0280
Reiner, 2017, Concise review: Developing best-practice models for the therapeutic use of extracellular vesicles, Stem Cells Translational Medicine, 6, 1730, 10.1002/sctm.17-0055
Zhang, 2016, Focus on extracellular vesicles: Therapeutic potential of stem cell-derived extracellular vesicles, Int J Mol Sci, 17, 174, 10.3390/ijms17020174
Lo Sicco, 2017, Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: Endorsement of macrophage polarization, Stem Cells Translational Medicine, 6, 1018, 10.1002/sctm.16-0363
Wen, 2016, Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells, Leukemia, 30, 2221, 10.1038/leu.2016.107
Xie, 2017, Extracellular vesicle-functionalized decalcified bone matrix scaffolds with enhanced pro-angiogenic and pro-bone regeneration activities, Sci Rep, 7, 45622, 10.1038/srep45622
Pachler, 2017, A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles, Cytotherapy, 19, 458, 10.1016/j.jcyt.2017.01.001
Rai, 2010, Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds, Biomaterials, 31, 7960, 10.1016/j.biomaterials.2010.07.001
Glennie, 2005, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, 105, 2821, 10.1182/blood-2004-09-3696
Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657
Gonzalez, 2009, Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells, Arthritis Rheum, 60, 1006, 10.1002/art.24405
Ren, 2011, Adhesion molecules: Key players in mesenchymal stem cell-mediated immunosuppression, Cell Adh Migr, 5, 20, 10.4161/cam.5.1.13491
Uccelli, 2008, Mesenchymal stem cells in health and disease, Nat Rev Immunol, 8, 726, 10.1038/nri2395
Kyurkchiev, 2014, Secretion of immunoregulatory cytokines by mesenchymal stem cells, World J Stem Cells, 6, 552, 10.4252/wjsc.v6.i5.552
Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554
Ren, 2008, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell, 2, 141, 10.1016/j.stem.2007.11.014
Lee, 2006, Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice, Proc Natl Acad Sci USA, 103, 17438, 10.1073/pnas.0608249103
Corrao, 2013, New frontiers in regenerative medicine in cardiology: The potential of Wharton's jelly mesenchymal stem cells, Curr Stem Cell Res Ther, 8, 39, 10.2174/1574888X11308010006
Anzalone, 2010, New emerging potentials for human Wharton's jelly mesenchymal stem cells: Immunological features and hepatocyte-like differentiative capacity, Stem Cells Dev, 19, 423, 10.1089/scd.2009.0299
Squillaro, 2016, Clinical trials with mesenchymal stem cells: An Update. Cell, Transplant, 25, 829
Miteva, 2016, Human endomyocardial biopsy specimen-derived stromal cells modulate angiotensin ii-induced cardiac remodeling, Stem Cells Translational Medicine, 5, 1707, 10.5966/sctm.2016-0031
Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat Rev Cancer, 16, 582, 10.1038/nrc.2016.73
Mattar, 2015, Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells, Front Immunol, 6, 560, 10.3389/fimmu.2015.00560
Rhee, 2015, Mesenchymal stem cell-mediated effects of tumor support or suppression, Int J Mol Sci, 16, 30015, 10.3390/ijms161226215
Klopp, 2007, Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment, Cancer Res, 67, 11687, 10.1158/0008-5472.CAN-07-1406
Lacerda, 2015, Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model, Breast Cancer Res, 17, 42, 10.1186/s13058-015-0549-4
Ridge, 2017, Mesenchymal stem cells: Key players in cancer progression, Mol Cancer, 16, 31, 10.1186/s12943-017-0597-8
Ye, 2012, Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer, Cancer Invest, 30, 513, 10.3109/07357907.2012.692171
Caimi, 2010, Emerging therapeutic approaches for multipotent mesenchymal stromal cells, Curr Opin Hematol, 17, 505, 10.1097/MOH.0b013e32833e5b18
Solchaga, 2010, Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells, Tissue Eng Part A, 16, 1009, 10.1089/ten.tea.2009.0100
Parsch, 2004, Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes, J Mol Med (Berl), 82, 49, 10.1007/s00109-003-0506-z
Zimmermann, 2003, Lack of telomerase activity in human mesenchymal stem cells, Leukemia, 17, 1146, 10.1038/sj.leu.2402962
Samsonraj, 2013, Telomere length analysis of human mesenchymal stem cells by quantitative PCR, Gene, 519, 348, 10.1016/j.gene.2013.01.039
Hemeda, 2014, Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells, Cytotherapy, 16, 170, 10.1016/j.jcyt.2013.11.004
Spees, 2004, Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy, Mol Ther, 9, 747, 10.1016/j.ymthe.2004.02.012
Bieback, 2013, Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures, Transfus Med Hemother, 40, 326, 10.1159/000354061
Bieback, 2009, Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow, Stem Cells, 27, 2331, 10.1002/stem.139
Wijesinghe, 2017, Affinity selection of FGF2-binding heparan sulfates for ex vivo expansion of human mesenchymal stem cells, J Cell Physiol, 232, 566, 10.1002/jcp.25454
Ling, 2016, Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells, Gene, 576, 292, 10.1016/j.gene.2015.10.039
Gibson, 2017, Regeneration of articular cartilage by human esc-derived mesenchymal progenitors treated sequentially with BMP-2 and Wnt5a, Stem Cells Translational Medicine, 6, 40, 10.5966/sctm.2016-0020
Eaker, 2013, Concise review: Guidance in developing commercializable autologous/patient-specific cell therapy manufacturing, Stem Cells Translational Medicine, 2, 871, 10.5966/sctm.2013-0050
Schnitzler, 2016, Bioprocessing of human mesenchymal stem/stromal cells for therapeutic use: Current technologies and challenges, Biochem Eng J, 108, 3, 10.1016/j.bej.2015.08.014
Research, 2017, 150
Nery, 2013, Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications, Cytometry Part A, 83A, 48, 10.1002/cyto.a.22205
Caplan, 2016, The 3Rs of cell therapy, Stem Cells Translational Medicine
Gronthos, 2007, A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells, Stem Cells Dev, 16, 953, 10.1089/scd.2007.0069
Bubnic, 2008
Smith, 2004, Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma, Stem Cells, 22, 823, 10.1634/stemcells.22-5-823
Gupta, 2013, A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia, J Transl Med, 11, 143, 10.1186/1479-5876-11-143